// App-Quantinova.ai

OP0183 (2021) : IDENTIFICATION OF A SUBGROUP OF PEOPLE WITH RHEUMATOID ARTHRITIS CHARACTERISED BY HIGH DISABILITY OVER 10 YEARS, DESPITE LOW INFLAMMATION: RESULTS FROM TWO EUROPEAN PROSPECTIVE COHORT STUDIES

Researchers

Presenter

  • J. Gwinnutt

Principal Investigators

  • S. Norton

  • K. Hyrich

  • M. Lunt

  • B. Combe

  • N. Rincheval

  • A. Ruyssen-Witrand

  • B. Fautrel

  • J. Chipping

  • A. Macgregor

  • S. Verstappen

Medical Centers

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • King’s College London, Health Psychology Section, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom

  • King’s College London, Department of Inflammation Biology, Faculty of Life Sciences and Medicine, London, United Kingdom

  • Manchester Academic Health Science Centre, National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom

  • The University of Montpellier, Department of Rheumatology, CHU Montpellier, Montpellier, France

  • The University of Montpellier, Laboratory of Biostatistics and Epidemiology, Montpellier, France

  • Hôpital Purpan, Centre de Rhumatologie, Toulouse, France

  • Pitie Salpetriere Hospital, Department of Rheumatology, Assistance Publique Hôpitaux de Paris, Paris, France

  • Sorbonne University, INSERM UMRS, Pierre Louis Institute of Epidemiology and Public Health, Paris, France

  • Medicine, University of East Anglia, Norwich Medical School, Norwich, United Kingdom

  • Norfolk and Norwich University Hospitals NHS Trust, Rheumatology Department, Norwich, United Kingdom

Locations

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bristol-Myer Squibb

Result

  • N/A